Carlson Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,889
| Closed | -$424K | – | 165 |
|
|
2023
Q4 | $424K | Buy |
3,889
+622
| +19% | +$64.6K | 0.02% | 130 |
|
|
2023
Q3 | $336K | Buy |
3,267
+9
| +0.3% | +$970 | 0.02% | 128 |
|
|
2023
Q2 | $376K | Sell |
3,258
-1,310
| -29% | -$149K | 0.02% | 123 |
|
|
2023
Q1 | $486K | Sell |
4,568
-54
| -1% | -$5.83K | 0.03% | 102 |
|
|
2022
Q4 | $513K | Buy |
4,622
+72
| +2% | +$7.36K | 0.04% | 96 |
|
|
2022
Q3 | $392K | Buy |
4,550
+329
| +8% | +$29.4K | 0.03% | 103 |
|
|
2022
Q2 | $385K | Sell |
4,221
-2,229
| -35% | -$198K | 0.03% | 108 |
|
|
2022
Q1 | $529K | Buy |
6,450
+18
| +0.3% | +$1.42K | 0.04% | 100 |
|
|
2021
Q4 | $493K | Buy |
6,432
+1,720
| +37% | +$137K | 0.04% | 97 |
|
|
2021
Q3 | $354K | Buy |
4,712
+194
| +4% | +$14.8K | 0.04% | 117 |
|
|
2021
Q2 | $351K | Sell |
4,518
-327
| -7% | -$24.3K | 0.05% | 108 |
|
|
2021
Q1 | $356K | Buy |
4,845
+111
| +2% | +$8.19K | 0.06% | 100 |
|
|
2020
Q4 | $375K | Sell |
4,734
-139
| -3% | -$10.6K | 0.07% | 89 |
|
|
2020
Q3 | $386K | Sell |
4,873
-722
| -13% | -$56.6K | 0.08% | 82 |
|
|
2020
Q2 | $410K | Buy |
5,595
+902
| +19% | +$67.9K | 0.09% | 78 |
|
|
2020
Q1 | $365K | Buy |
4,693
+454
| +11% | +$35.7K | 0.09% | 73 |
|
|
2019
Q4 | $368K | Buy |
4,239
+16
| +0.4% | +$1.31K | 0.08% | 74 |
|
|
2019
Q3 | $339K | Buy |
4,223
+541
| +15% | +$43.4K | 0.08% | 67 |
|
|
2019
Q2 | $295K | Sell |
3,682
-6
| -0.2% | -$459 | 0.07% | 72 |
|
|
2019
Q1 | $293K | Buy |
3,688
+448
| +14% | +$33.5K | 0.07% | 72 |
|
|
2018
Q4 | $236K | Sell |
3,240
-105
| -3% | -$7.41K | 0.07% | 71 |
|
|
2018
Q3 | $226K | Buy |
+3,345
| New | +$213K | 0.06% | 82 |
|
|
2018
Q1 | – | Sell |
-4,411
| Closed | -$237K | – | 87 |
|
|
2017
Q4 | $237K | Buy |
4,411
+301
| +7% | +$16.7K | 0.06% | 74 |
|
|
2017
Q3 | $251K | Buy |
4,110
+425
| +12% | +$25.8K | 0.07% | 66 |
|
|
2017
Q2 | $225K | Sell |
3,685
-184
| -5% | -$11.2K | 0.07% | 70 |
|
|
2017
Q1 | $235K | Buy |
3,869
+166
| +4% | +$10.1K | 0.08% | 51 |
|
|
2016
Q4 | $208K | Sell |
3,703
-241
| -6% | -$14.1K | 0.07% | 53 |
|
|
2016
Q3 | $235K | Hold |
3,944
| – | – | 0.08% | 55 |
|
|
2016
Q2 | $217K | Buy |
+3,944
| New | +$210K | 0.08% | 56 |
|
|
2015
Q3 | – | Sell |
-4,053
| Closed | -$220K | – | 60 |
|
|
2015
Q2 | $220K | Buy |
4,053
+145
| +4% | +$8.13K | 0.08% | 55 |
|
|
2015
Q1 | $214K | Buy |
+3,908
| New | +$221K | 0.08% | 55 |
|
Other funds holding MRK
Carlson Capital Management's MRK Position: Q1 2024 in Review
Carlson Capital Management sold out of Merck (MRK) in Q1 2024, closing a stake of 3,889 shares — an estimated $424K sold.
Carlson Capital Management first reported a position in MRK in Q1 2015 and held it in 31 quarters. The position peaked at $529K in Q1 2022. 3,535 funds tracked by Wall St. Rank hold MRK as of Q1 2024.
- Carlson Capital Management reported no remaining Merck position as of Q1 2024 after selling out during the quarter.
- Carlson Capital Management sold 3,889 Merck shares in Q1 2024, an estimated $424K.
- Carlson Capital Management first reported a position in Merck in Q1 2015 and held it in 31 quarters.
- Carlson Capital Management's Merck position peaked at $529K in Q1 2022.
- 3,535 funds tracked by Wall St. Rank held Merck as of Q1 2024.
Based on Carlson Capital Management's 13F filing for Q1 2024, filed 12 Apr 2024.